Immune-regulatory (FoxP3+)-T-cell tumor infiltration status is predictive of benefit from chemo-immunotherapy with gemcitabine, oxaliplatin, 5FU/FA plus GM-CSF and aldesleukine (GOLFIG) in metastatic colon cancer patients

Autor:	Remondo, C, Tagliaferri, P, M S, Rotundo, Tassone, P, M T, Del Vecchio, Migali, C, Francini, G, Correale, P
Jazyk:	angličtina
Rok vydání:	2009
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______1820::7250c70e6a6c2f712dcdd28455568759 http://hdl.handle.net/11365/35508 Zobrazit plný text záznamu